A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2009
11/25/2009	EP1268509B1 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof
11/25/2009	EP0954585B1 Human telomerase reverse transcriptase promoter
11/25/2009	CN101589062A Compositions and methods relating to glucagon receptor antibodies
11/25/2009	CN101589061A Antibody molecules which bind IL-17A and IL-17F
11/25/2009	CN101589059A Pharmaceutical composition comprising anti-HB-EGF antibody as active ingredient
11/25/2009	CN101589058A Cancer therapeutic agent comprising anti-HB-EGF antibody as active ingredient
11/25/2009	CN101588817A Fully human high yield production system for improved antibodies and proteins
11/25/2009	CN101588816A High affinity antibody antagonists of interleukin-13 receptor alpha 1
11/25/2009	CN101588815A Novel prostate kallikrein allergen
11/25/2009	CN101588814A Methods for treating, preventing and diagnosing porcine TTV infection
11/25/2009	CN101588813A Method of inducing neutralizing antibodies to human immunodeficiency virus
11/25/2009	CN101586143A Modulating production of pneumococcal capsular polysaccharide
11/25/2009	CN101586142A Research approach for element for forcing knubble microenvironment and application thereof
11/25/2009	CN101586120A Rabies virus Flury-LEP vaccine strain reverse genetic operating system and LEP green fluorescent protein recombination viral vector
11/25/2009	CN101586106A The genome of the hiv-1 inter-subtype (c/b') and use thereof
11/25/2009	CN101585881A An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/25/2009	CN101585880A Variable regions on heavy and light chains of antihuman IL-13R alpha 2 monoclonal antibodies
11/25/2009	CN101584862A Diagnosing tumorigenicity and determining resistance to anticancer therapy
11/25/2009	CN101584861A Methods for enhancing innate and adaptive immunity and antigen immunogenicity
11/25/2009	CN101584860A Recombinant human Claudin18.2 tumor vaccine and preparation method thereof
11/25/2009	CN101584854A Romurtide cyclodextrin inclusion compound, preparation thereof and method for preparing same
11/25/2009	CN100562570C Modified recombinant vaccinia viruses and other microorganisms, uses thereof
11/25/2009	CN100562339C Remedies for infact chronic arthritis-relating diseases
11/25/2009	CN100562338C Beta-amyloid-analogue-cell epitop vaccine
11/24/2009	US7623971 Method, system and computer program product for technical management and biocontrol of disease in animal production systems
11/24/2009	US7622571 Methods and compositions for Mycoplasma pneumoniae exotoxins
11/24/2009	US7622569 The 98P4B6 gene, its fragment, its encoded protein, variants , or a fragment, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 98P4B6 can be used in active or passive immunization
11/24/2009	US7622560 Expressed on human acute leukemia, lymphoblastic lymphoma cells, but not on mature hematopoietic cells, hematopoietic stem cells and non-hematopoietic cells; kits; immunohistochemistry
11/24/2009	US7622559 Chemokine specific immunoglobulin for prevention and treatment of cell proliferative, skin, inflammatory and autoimmune disorders
11/24/2009	US7622556 Modified cytokines for use in cancer therapy
11/24/2009	US7622549 Human telomerase reverse transcriptase polypeptides
11/24/2009	US7622457 Polynucleotides encoding anticoagulant fusion proteins
11/24/2009	US7622444 Methods for using OX-40 ligand to enhance an antigen specific immune response
11/24/2009	US7622442 Interacting the immature dendritic cells with an antigen ex vivo so that the surface antigen is presented; inducing maturation ex vivo; and contacting with a modulator comprising TRANCE; an increased viability relative to a control dendritic cell not contacted with TRANCE
11/24/2009	US7622297 Administering a polynucleotide encoding a Mycrobacterium kansasii-derived alpha antigen; asthma, atopic dermatitis, allergic rhinitis, allergic conjunctivitis
11/24/2009	US7622272 Treating cell proliferation disease; aberrant fetoplacental growth; cancer
11/24/2009	US7622125 Polycistronic HIV vector constructs
11/24/2009	US7622124 Also contains an antigen of swine influenza virus, porcine reproductive and respiratory syndrome virus, or porcine circovirus; an acrylic acid polymer, metabolizable oil and an oxyethylene-oxypropylene block polymer as adjuvant
11/24/2009	US7622123 A chimeric, infectious human-bovine chimeric parainfluenza virus (PIV) comprising a major nucleocapsid protein, a nucleocapsid phosphoprotein , a large polymerase protein, and a PIV background genome or antigenome of a human PIV3 combined with a M gene or genome segment of bovin PIV
11/24/2009	US7622122 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome; targeting protein, that interacts with tissue factor or the factor VIIa/tissue factor complex
11/24/2009	US7622121 Heat shock proteins from Mycobacterium leprae and uses thereof
11/24/2009	US7622120 Peptide originating from vaccinia virus
11/24/2009	US7622119 Wilm's tumor amino acid sequences for use as tissue targeted agent for treatment of cell proliferative disorders
11/24/2009	US7622118 Cancer treatment methods using selected antibodies to aminophospholipids
11/24/2009	US7622116 Method of treating inflammation using soluble IL-17RCX4
11/24/2009	US7622115 Treatment with anti-VEGF antibodies
11/24/2009	US7622114 Measuring the level of NR2A and/or NR2B NMDA receptor; for diagnosing stroke in an emergency room setting
11/24/2009	US7622113 Monoclonal antibodies that bind or neutralize dengue virus
11/24/2009	US7622112 Anti-SARS monoclonal antibodies
11/24/2009	US7622111 Fusion protein of human IgG1 heavy chain constant region and scFv antibody against equine encephalitis virus
11/24/2009	US7622110 Using interleukin beta specific immunoglobulin as blocking agent and preventative of juvenile idiopathic arthritis
11/24/2009	US7622107 Recombinant intracellular pathogen immunogenic compositions and methods for use
11/24/2009	CA2423384C New cross-linked derivatives of hyaluronic acid
11/24/2009	CA2374513C Il-1 eta dna and polypeptides
11/24/2009	CA2303063C Mage-3 peptides presented by hla class ii molecules
11/24/2009	CA2203182C Remedy for diseases caused by il-6 production
11/24/2009	CA2201105C Inhibitor of stem cell proliferation and uses thereof
11/24/2009	CA2141574C Herpesvirus vaccines
11/19/2009	WO2009140684A2 Use of biomarkers for assessing treatment of gastrointestinal inflammatory disorders with beta7integrin antagonists
11/19/2009	WO2009140676A2 Compositions and methods for inhibition of retroviruses
11/19/2009	WO2009140649A2 Rab3b for the treatment and prevention of parkinson's disease
11/19/2009	WO2009140623A2 Anti-psgl-1 antibodies and methods of identification and use
11/19/2009	WO2009140549A1 Combinations vegf(r) inhibitors and hepatocyte growth factor (c-met) inhibitors for the treatment of cancer
11/19/2009	WO2009140469A2 Methods of using apo2l/trail to treat cancer
11/19/2009	WO2009140361A1 ANTI-PirB ANTIBODIES
11/19/2009	WO2009140323A2 Zero-valent metallic treatment system and its applicaton for removal and remediation of polychlorinated biphenyls
11/19/2009	WO2009140236A2 Staphylococcus aureus-specific antibody preparations
11/19/2009	WO2009140177A2 Anti-fn14 antibodies and uses thereof
11/19/2009	WO2009140124A1 Anti-cxcr4 antibodies
11/19/2009	WO2009139985A2 Methods and materials for gastrointestinal delivery of pathogen/toxin binding agents
11/19/2009	WO2009139928A2 Recombinant chimeric antigens for diagnosis and prevention of scrub typhus
11/19/2009	WO2009139921A2 Microorganisms for preventing and treating neoplasms accompanying cellular therapy
11/19/2009	WO2009139853A2 Human monoclonal antibodies against human chemokine receptor ccr7
11/19/2009	WO2009139822A1 Anti-hepcidin antibodies and methods of use
11/19/2009	WO2009139766A1 Anticancer combination therapy including triciribine
11/19/2009	WO2009139459A1 Method for prevention and treatment of metabolic syndrome through the inhibition of psgl-1
11/19/2009	WO2009138850A1 Hematopoietic cells expressing the protein susd3 and ligands for the protein susd3
11/19/2009	WO2009138752A2 Fish vaccine
11/19/2009	WO2009138533A1 Set of antiangiogenic molecules and use thereof
11/19/2009	WO2009138519A1 AMINO ACID SEQUENCES DIRECTED AGAINST CXCR4 AND OTHER GPCRs AND COMPOUNDS COMPRISING THE SAME
11/19/2009	WO2009138220A1 Fermentation process
11/19/2009	WO2009138094A1 Pharmaceutical compositions
11/19/2009	WO2009137872A1 Methods and compositions for the treatment of cancer
11/19/2009	WO2009137871A1 Methods of detecting cells with a disrupted cell membrane, cells infected with a pathogen, dying cells or dead cells
11/19/2009	WO2009108932A3 Selectin ligands useful in the diagnosis and treatment of cancer
11/19/2009	WO2009105230A3 Methods for treating cancer using combination therapy
11/19/2009	WO2009100422A3 Drug delivery system comprising microparticles and gelation system
11/19/2009	WO2009099716A4 Novel vaccines against multiple subtypes of dengue virus
11/19/2009	WO2009049184A9 Systemic administration of chlorotoxin agents for the diagnosis and treatment of tumors
11/19/2009	WO2009040413A3 An ex vivo, fast and efficient process to obtain activated antigen-presenting cells that are useful for therapies against cancer and immune system-related diseases
11/19/2009	WO2009023386A3 Binding peptides having a c-terminally disposed specific binding domain
11/19/2009	WO2009010877A3 Conjugate purification
11/19/2009	WO2008119567A8 Cross-species-specific cd3-epsilon binding domain
11/19/2009	WO2003064450A9 Epizootic catarrhal enteritis prevention, treatment and diagnosis
11/19/2009	US20090288179 Inactivated Nodavirus Vaccine
11/19/2009	US20090288178 Insect cell line for production of recombinant glycoproteins with sulfated complex n-glycans
11/19/2009	US20090288176 Novel Gene Disruptions, Compositions and Methods Relating Thereto
11/19/2009	US20090287313 Tissue adhesive sealant
11/19/2009	US20090286963 Antigenic fusion protein carrying gal alpha1,3gal epitopes
11/19/2009	US20090286865 Potentiator of antitumoral agents in the treatment of cancer

1 ... 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 ... 1823